Primary treatment of kawasaki disease with corticosteroids (original) (raw)
Chinese National Consensus Committee of Experts on Kawasaki Disease and Chinese Journal of Contemporary Pediatrics: The expert consensuses on Intravenous Immunoglobulin, aspirin, and Glucocorticoid
fuyong jiao
Research Square (Research Square), 2022
View PDFchevron_right
The use of corticosteroid therapy in refractory Kawasaki patients
Sulaiman M Al-Mayouf
Clinical Rheumatology, 2004
View PDFchevron_right
Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications
Gabriella De Rosa
PubMed, 2007
View PDFchevron_right
Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids
robert sundel
The Journal of Pediatrics, 1996
View PDFchevron_right
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease
Paul Mitchell
New England Journal …, 2007
View PDFchevron_right
Intravenous pulsed corticosteroid therapy for primary treatment of Kawasaki Disease
Luis Ramiro Peñafiel Espinoza
Current Rheumatology Reports, 2007
View PDFchevron_right
Controversies in the medical management of Kawasaki disease
Jose Ettedgui
Cardiology in the Young, 1991
View PDFchevron_right
Corticosteroid therapy for primary treatment of Kawasaki disease – weight of evidence: a meta-analysis and systematic review of the literature
Seth Gale
Cardiovascular Journal of Africa, 2009
View PDFchevron_right
Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin
Michael Dillon
The Journal of Pediatrics, 2000
View PDFchevron_right
Successful management of a child with Kawasaki disease complicated by acute myocardial infarction
Ahmed Sghaier
Cor et Vasa, 2019
View PDFchevron_right
Impact of Early Treatment with High-Dose Intravenous Immunoglobulin on Incidence of Kawasaki Disease Complications in Iranian Children
leyla sahebi
Journal of Family & Reproductive Health
View PDFchevron_right
Clinical Profiles of the Children's Suffering from Kawasaki Disease and Its Outcomes
Ammara Iqbal
2020
View PDFchevron_right
Kawasaki disease: diagnosis, management, and long-term implications
Gary Satou
Cardiology in review
View PDFchevron_right
Indian Academy of Pediatrics Position Paper on Kawasaki Disease
Dr. Vijay Viswanathan
Indian Pediatrics, 2020
View PDFchevron_right
Changing Management of Kawasaki Disease
Raffaele Domenici
View PDFchevron_right
Associated Symptoms in the Ten Days Before Diagnosis of Kawasaki Disease
Jane Newburger
The Journal of Pediatrics, 2009
View PDFchevron_right
Review of Kawasaki Disease
Ashwini Mallad
Marshall Journal of Medicine, 2018
View PDFchevron_right
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
Lloyd Tani
Circulation, 2004
View PDFchevron_right
Clinical aspects of 100 patients with Kawasaki disease
Michael Dillon
Archives of Disease in Childhood, 1991
View PDFchevron_right
Cardiac complications in children with Kawasaki disease in our own experience
Hanna Górzna-Kamińska
Kardiologia Polska, 2016
View PDFchevron_right
Clinical, Developing and Therapeutic Stages in a Kawasaki's Disease Case Report
eulalia boceanu
View PDFchevron_right
Young, American Heart Association Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Statement for Health Professionals From the Committee on Rheumatic Fever, Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A
Kathryn Taubert
2004
View PDFchevron_right
Kawasaki Disease in Children: A Brief Update
kamrul laila
Journal of Bangladesh College of Physicians and Surgeons, 2024
View PDFchevron_right
Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
Srini Kaveri
Drug Discovery Today, 2016
View PDFchevron_right
Coronary Involvement in Infants with Kawasaki Disease Treated with Intravenous γ-Globulin
Fernando Castillo
Pediatric Cardiology, 2008
View PDFchevron_right
Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
MARIA PACENCIA PAMINTUAN
Pediatrics & Neonatology, 2014
View PDFchevron_right
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol
Rachael McCormack
Trials
View PDFchevron_right
Refractory Kawasaki Disease—a Challenge for the Pediatrician
Sridhar Kalyanasundaram
SN Comprehensive Clinical Medicine
View PDFchevron_right
Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis
Nagib Dahdah
Pediatrics, 2019
View PDFchevron_right
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
Kathryn Taubert
Circulation, 2004
View PDFchevron_right
Kawasaki Disease: Heart Disease During Childhood
Roberto Miatello
Revista Española de Cardiología (English Edition), 2006
View PDFchevron_right